Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United States
The incidence of high-grade squamous intraepithelial lesions or worse is decreasing, with large reductions in the prevalence of quadrivalent HPV vaccine types and nonvaccine types HPV-31 and HPV-33, reflecting vaccine cross-protection. Increases in nonvaccine HPV genotypes may attenuate anticipated reductions in HPV-related abnormalities, including cancers, but the benefits of HPV vaccination remain substantial.
Authors
- Ruth McDonald
- Steven Jenison
- Debbie Saslow
- Jack Cuzick (ORCID: https://orcid.org/0000-0001-7420-7512)
- Cosette M. Wheeler (ORCID: https://orcid.org/0000-0003-3229-5846)
- Nancy E. Joste
- Michael J. Robertson (ORCID: https://orcid.org/0000-0003-2610-680X)
- Rachael Adcock (ORCID: https://orcid.org/0000-0003-2856-7108)
- Jane J. Kim (ORCID: https://orcid.org/0000-0002-9892-9170)
- Philip E. Castle (ORCID: https://orcid.org/0000-0003-1082-6554)
- Norah Torrez‐Martinez
- William C. Hunt
- Emily Merchasin
Institutions
- American Cancer Society (US)
- Queen Mary University of London (GB)
- University of New Mexico (US)
- Management Sciences for Health (US)
- National Cancer Institute (US)
- New Mexico Cancer Center (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2024-12-07
- DOI
- https://doi.org/10.1093/jnci/djae327
- Citations
- 6
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 2.32
Funders
- U.S. Department of Health and Human Services
- Queen Mary University of London
- National Institutes of Health
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases